[一种用于异基因造血干细胞移植后供体嵌合体及其临床效果的新型定量方法] - Suppr | 超能文献

[A novel quantitative approach to donor chimerism and its clinical effect after allogenic hematopoietic stem cell transplantation].

作者信息

Zhen Zi-jun, Fang Jian-pei, Li Chi-kong

出版信息

Zhonghua Er Ke Za Zhi. 2006 Jul;44(7):540-1.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[A novel quantitative approach to donor chimerism and its clinical effect after allogenic hematopoietic stem cell transplantation].[一种用于异基因造血干细胞移植后供体嵌合体及其临床效果的新型定量方法]

Zhonghua Er Ke Za Zhi. 2006 Jul;44(7):540-1.

2

Full donor chimerism using stem-cell transplantation for tolerance induction in the human leukocyte antigen-matched liver transplant setting.在人类白细胞抗原匹配的肝移植环境中，使用干细胞移植实现完全供体嵌合以诱导免疫耐受。

Transplantation. 2009 Aug 27;88(4):601-3. doi: 10.1097/TP.0b013e3181b164d5.

3

Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma.在减低强度预处理的异基因造血干细胞移植后进行部分 T 细胞耗竭，为多发性骨髓瘤患者使用供者淋巴细胞输注和受者树突状细胞疫苗进行免疫治疗创造了平台。

Biol Blood Marrow Transplant. 2010 Mar;16(3):320-32. doi: 10.1016/j.bbmt.2009.10.006. Epub 2009 Oct 14.

4

In situ chimerism after double cord blood transplantation.双份脐血移植后的原位嵌合现象。

Bone Marrow Transplant. 2013 Nov;48(12):1582. doi: 10.1038/bmt.2013.102. Epub 2013 Jul 22.

5

Usefulness of Post-Transplant Hematopoietic Chimera Monitoring by Use of the Quantitative Fluorescence Polymerase Chain Reaction Method.运用定量荧光聚合酶链反应法监测移植后造血嵌合体的效用

Transplant Proc. 2017 Oct;49(8):1903-1910. doi: 10.1016/j.transproceed.2017.04.013.

6

CD34+ cell dose, conditioning regimen and prior chemotherapy: factors with significant impact on the early kinetics of donor chimerism after allogeneic hematopoietic cell transplantation.CD34+细胞剂量、预处理方案及既往化疗：对异基因造血细胞移植后供体嵌合体早期动力学有显著影响的因素。

Bone Marrow Transplant. 2004 Dec;34(11):949-54. doi: 10.1038/sj.bmt.1704710.

7

Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.在进行非清髓性预处理后输注供体干细胞，以诱导对 HLA 不匹配的成人活体供肝移植的耐受性。

Transpl Immunol. 2004 Sep-Oct;13(2):139-46. doi: 10.1016/j.trim.2004.05.004.

8

[Quantitative monitoring of multi-donor chimerism after multi-donor allogeneic hematopoietic stem cell transplantation].[多供体异基因造血干细胞移植后多供体嵌合体的定量监测]

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Apr;21(2):436-40. doi: 10.7534/j.issn.1009-2137.2013.02.037.

9

Allogeneic stem cell transplantation using myeloablative and reduced-intensity conditioning in patients with major histocompatibility complex class II deficiency.同种异体干细胞移植使用清髓性和强度降低的预处理方案治疗主要组织相容性复合体 II 类缺陷患者。

Biol Blood Marrow Transplant. 2010 Jun;16(6):818-23. doi: 10.1016/j.bbmt.2010.01.002. Epub 2010 Jan 14.

10

[Clinical significance of formation and conversion of hematopoietic mixed chimerism in nonmyeloablative allogeneic stem cell transplantation].[非清髓性异基因造血干细胞移植中造血混合嵌合体形成与转化的临床意义]

Zhonghua Yi Xue Za Zhi. 2003 Feb 10;83(3):208-11.